VIVUS Inc. (NASDAQ:VVUS) reported a loss of 1 cent per share in the first quarter of 2017, which was narrower than a loss of 12 cents in the year-ago period as well as the Zacks...
GlaxoSmithKline plc’s (NYSE:GSK) first quarter results came roughly in line with expectations. Glaxo reported first-quarter 2017 core earnings of 62 cents per American...
AbbVie Inc. (NYSE:ABBV) announced that data from two phase III studies, EXPEDITION-1 and ENDURANCE-3, evaluating its investigational, pan-genotypic regimen of...
The announcement of Nivalis Therapeutics, Inc.’s (NASDAQ:NVLS) merger agreement with a privately-held biotechnology company, Alpine Immune Sciences, Inc. failed to excite...
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced the submission of a supplemental New Drug Application (sNDA) to the FDA for the subcutaneous auto-injector form of its marketed...
Wall Street is getting ugly, but we nailed some nice trades intraday. We’ll try to keep that up and keep the mojo going in the trading room. But, for now, it’s an ugly...
It was a strange day on Wall Street. The stock market had a strong opening on Monday. Resistance was had, and then a 5-wave decline ensured, followed by a 3-wave rally. The close...
The stock market got smacked on Wednesday. Most of the stocks that we were trading were ultra-shorts and eboli drug-related stocks, and pretty much that was it. It wasn’t a...
It was a lousy day on Wall Street on Monday, but proved positive that you can trade on the wrong side if you have the right stock as we did today. These two are the first two...
berenberg forecast for grifols...100%https://www.expansion.com/mercados/2022/08/04/62eb6b09e5fdea576b8b4615.html
1
So far very happy with this investment. The position I started on january 2022 is doing pretty well.
1
rumours..
0
facts
0
always in with some shares..
0
Veo que hay mucha confusión por parte de muchos usuarios a la hora de interpretar los datos de esta página web. En investing no es posible seguir en tiempo real la cotización de Grifols. Si se selecciona la opción 'tiempo real', como claramente se indica, lo que se está viendo es un producto derivado, no la cotización real de Grifols. Si se selecciona la opción 'demorada', esa es la cotización real de Grifols, que incluye el cierre diario. Si cambiáis entre tiempo real y demorada veréis que los datos no siempre son iguales. Por tanto, la página 'no está mal': en tiempo real, lo que vemos no es la cotización de Grifols, es otro producto financiero. A ver si eso ayuda a esclarecer este malentendido.